The Translational Cancer and Immunity Center
Back to Research PageInterdisciplinary Research Program (IDRP) - Integrative, Translational Research Against COVID-19
Aim
This program aims to (1) develop diagnostic and predictive biomarkers for infection, COVID-19 complications and immunity, (2) identify the therapeutic potential for preventing infection and treating COVID-19 using in-house tools and models, and (3) build capacity for research, development and innovation and foster preparedness in Qatar against coronaviruses.
Scientific Coordinators
Investigators
-
Dr. Nehad Alajez
Translational Cancer and Immunity Center (TCIC) -
Dr. Khalid Ouararhni
Translational Cancer and Immunity Center (TCIC) -
Dr. Paul Thornalley
Diabetes Research Center (DRC) -
Dr. Prasanna Kolatkar
Diabetes Research Center (DRC) -
Dr. Abdelilah Arredouani
Diabetes Research Center (DRC) -
Dr. Heba Al-Siddiqi
Diabetes Research Center (DRC) -
Dr. Omar El-Agnaf
Neurological Disorders Research Center (NDRC) -
Dr. Hyung Kim
Neurological Disorders Research Center (NDRC) -
Dr. Yongsoo Park
Neurological Disorders Research Center (NDRC) -
Dr. Sara Abdulla
Neurological Disorders Research Center (NDRC) -
Dr. Houari Abdesselem
Neurological Disorders Research Center (NDRC)
Collaborators
- Dr. Mariam Al-Nesf
Hamad Medical Corporation (HMC) - Dr. Jassim Al-Suwaidi
Hamad Medical Corporation (HMC) - Dr. Ali Omrani
Hamad Medical Corporation (HMC) - Dr. Nahla Afifi
Qatar Biobank - Dr. Vidya Mohamed-Ali
Anti-Doping Lab Qatar (ADL-Q) - Dr. Mohammed Al-Madheedh
Anti-Doping Lab Qatar (ADL-Q) - Dr. Hadi Yassine
Qatar University (QU) - Dr. Hebah Al Khatib
Qatar University (QU) - Dr. Naila Rabbani
Qatar University (QU)
- Resources
- موارد
MYHBKU LOGIN
تسجيل دخول بنر